1. Home
  2. CCCC vs EH Comparison

CCCC vs EH Comparison

Compare CCCC & EH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.41

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Logo EHang Holdings Limited ADS

EH

EHang Holdings Limited ADS

HOLD

Current Price

$4.55

Market Cap

436.9M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
EH
Founded
2015
2014
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
436.9M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
CCCC
EH
Price
$3.41
$4.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
3
Target Price
$12.20
$22.47
AVG Volume (30 Days)
1.8M
738.4K
Earning Date
05-06-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
16.45
N/A
EPS
N/A
N/A
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
$33.23
Revenue Next Year
N/A
$73.83
P/E Ratio
N/A
N/A
Revenue Growth
1.02
N/A
52 Week Low
$1.69
$4.31
52 Week High
$5.17
$20.20

Technical Indicators

Market Signals
Indicator
CCCC
EH
Relative Strength Index (RSI) 37.75 39.40
Support Level $3.38 $4.35
Resistance Level $3.91 $4.91
Average True Range (ATR) 0.17 0.19
MACD -0.04 0.03
Stochastic Oscillator 13.82 42.02

Price Performance

Historical Comparison
CCCC
EH

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About EH EHang Holdings Limited ADS

EHang Holdings Ltd is an urban air mobility (UAM) technology platform company focused on autonomous aerial vehicle technology and solutions. The company provides unmanned aerial vehicle (UAV) systems and solutions for air mobility, including passenger transportation and logistics, as well as smart city management and aerial media solutions. Its EH216-S passenger-carrying pilotless eVTOL aircraft has obtained a production certificate and standard airworthiness certificate from the Civil Aviation Administration of China (CAAC).

Share on Social Networks: